Sarcopenia is the loss of muscle strength, mass, and function, which is often exacerbated by
chronic comorbidities including cardiovascular diseases, chronic kidney disease, and …

In a world in which life expectancy is increasing, understanding and promoting healthy
aging becomes a contemporary demand. In the elderly, a sterile, chronic and low-grade …

Sarcopenic obesity is defined as a multifactorial disease in aging with decreased body
muscle, decreased muscle strength, decreased independence, increased fat mass, due to …

Sarcopenic obesity is becoming a global health concern, owing to the rising older
population, causing cardiometabolic morbidity and mortality. Loss of muscle exceeding …

Osteosarcopenic obesity is a unique clinical condition where low bone and muscle mass
coexist in individuals with obesity. Alterations in adipose tissue, skeletal muscle and bone …

Sarcopenia is a disease that becomes more prevalent as the population ages, since it is
directly linked to the process of senility, which courses with muscle atrophy and loss of …

For a century, since the pioneering work of Otto Warburg, the interwoven relationship
between metabolism and cancer has been appreciated. More recently, with obesity rates …

Background The aim of this study was to investigate the associations of osteosarcopenic
obesity (OSO) and its components with complete blood cell count-derived inflammation …

Background & aims Ageing brings alterations in body composition, as skeletal muscle
gradually declines and accumulation of adipose tissue accompanies it. Although sarcopenia …

Sarcopenic obesity (SO) constitutes the coexistence of skeletal muscle mass loss
(sarcopenia) and excess adiposity (obesity). It is mainly considered as a condition in the …